The store will not work correctly when cookies are disabled.
2-Chloro-9-((6-cyclopentylpyridin-2-yl)methyl)-9H-purin-6-amine
ID: ALA4790482
PubChem CID: 162668470
Max Phase: Preclinical
Molecular Formula: C16H17ClN6
Molecular Weight: 328.81
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(Cl)nc2c1ncn2Cc1cccc(C2CCCC2)n1
Standard InChI: InChI=1S/C16H17ClN6/c17-16-21-14(18)13-15(22-16)23(9-19-13)8-11-6-3-7-12(20-11)10-4-1-2-5-10/h3,6-7,9-10H,1-2,4-5,8H2,(H2,18,21,22)
Standard InChI Key: OJCLSOHWOVKXMM-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
12.4728 -6.1581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9501 -6.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4631 -7.4804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6886 -7.2259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9753 -7.6272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2704 -7.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2789 -6.3982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9881 -5.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6929 -6.4088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9925 -5.1757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7097 -8.2603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5104 -8.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0605 -7.8344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8570 -8.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1036 -8.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5536 -9.3900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7570 -9.2150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8002 -10.1698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5789 -10.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5704 -11.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7906 -11.4921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3173 -10.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5612 -7.6166 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
1 9 1 0
4 9 1 0
8 10 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
18 22 1 0
16 18 1 0
11 12 1 0
3 11 1 0
6 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 328.81 | Molecular Weight (Monoisotopic): 328.1203 | AlogP: 3.16 | #Rotatable Bonds: 3 |
Polar Surface Area: 82.51 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.13 | CX LogP: 2.99 | CX LogD: 2.99 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -1.05 |
References
1. Huang Y,Wu XN,Zhou Q,Wu Y,Zheng D,Li Z,Guo L,Luo HB. (2020) Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors., 63 (24): [PMID:33291877] [10.1021/acs.jmedchem.0c01573] |